Article
CRISPR/Cas9 Genome Editing as a Strategy to Study the Tumor Microenvironment in Transgenic Mice.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2016
Yamanaka Yojiro
Abstract excerpt
Development of engineered site-specific endonucleases like zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR/Cas9 has been revolutionizing genetic approaches in biomedical research fields. These new tools have opened opportunities to carry out targeted genome editing in mouse zygotes without the need for manipulating embryonic stem cells, which have a higher...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
